NeoGenomics (NEO) Reports In-Line Q3 EPS

NeoGenomics (NASDAQ: NEO) reported Q3 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $23.2 million versus the consensus estimate of $22.43 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Jana Partners urges Cooper Companies to replace CEO and explore asset sales
• Nucor projects Q3 2026 earnings above prior year, below estimates